Business Description
Wakamoto Pharmaceutical Co Ltd
ISIN : JP3991200001
Description
Wakamoto Pharmaceutical Co Ltd is the pharmaceutical company based in Japan. It is engaged in the research and development, production and sale of ethical drugs and non-prescription drugs. The company specializes in therapeutic and diagnostic agents for ophthalmic disorders. It offers Strong Wakamoto, a gastrointestinal drug for digestion, the intestinal function controlling, and nutritional supply.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 35.61 | |||||
| Equity-to-Asset | 0.77 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -7.54 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 2.8 | |||||
| Beneish M-Score | -2.45 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -7.4 | |||||
| 3-Year Book Growth Rate | -0.1 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 72.92 | |||||
| 9-Day RSI | 64.15 | |||||
| 14-Day RSI | 61.11 | |||||
| 6-1 Month Momentum % | 17.77 | |||||
| 12-1 Month Momentum % | -7.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.52 | |||||
| Quick Ratio | 3.45 | |||||
| Cash Ratio | 1.86 | |||||
| Days Inventory | 170.97 | |||||
| Days Sales Outstanding | 126.51 | |||||
| Days Payable | 80.5 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.54 | |||||
| Forward Dividend Yield % | 2.54 | |||||
| 5-Year Yield-on-Cost % | 2.54 | |||||
| Shareholder Yield % | 2.59 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 46.98 | |||||
| Operating Margin % | -1.9 | |||||
| Net Margin % | -2.23 | |||||
| FCF Margin % | 5.27 | |||||
| ROE % | -1.5 | |||||
| ROA % | -1.15 | |||||
| ROIC % | -18.31 | |||||
| ROC (Joel Greenblatt) % | -0.21 | |||||
| ROCE % | -0.1 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.03 | |||||
| PB Ratio | 0.69 | |||||
| Price-to-Tangible-Book | 0.72 | |||||
| Price-to-Free-Cash-Flow | 19.55 | |||||
| Price-to-Operating-Cash-Flow | 13.01 | |||||
| EV-to-EBIT | -359.06 | |||||
| EV-to-EBITDA | -359.06 | |||||
| EV-to-Revenue | 0.59 | |||||
| EV-to-FCF | 10.66 | |||||
| Price-to-Projected-FCF | 0.88 | |||||
| Price-to-Median-PS-Value | 1.14 | |||||
| Price-to-Net-Current-Asset-Value | 1.61 | |||||
| Price-to-Net-Cash | 1128.57 | |||||
| Earnings Yield (Greenblatt) % | -0.28 | |||||
| FCF Yield % | 5.12 | |||||
| Forward Rate of Return (Yacktman) % | -26.71 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Wakamoto Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 7,978.781 | ||
| EPS (TTM) (円) | -5.125 | ||
| Beta | 0.23 | ||
| Volatility % | 21.87 | ||
| 14-Day RSI | 61.11 | ||
| 14-Day ATR (円) | 5.359686 | ||
| 20-Day SMA (円) | 231.85 | ||
| 12-1 Month Momentum % | -7.57 | ||
| 52-Week Range (円) | 189 - 261 | ||
| Shares Outstanding (Mil) | 34.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Wakamoto Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Wakamoto Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Wakamoto Pharmaceutical Co Ltd Frequently Asked Questions
What is Wakamoto Pharmaceutical Co Ltd(TSE:4512)'s stock price today?
The current price of TSE:4512 is 円237.00. The 52 week high of TSE:4512 is 円261.00 and 52 week low is 円189.00.
When is next earnings date of Wakamoto Pharmaceutical Co Ltd(TSE:4512)?
The next earnings date of Wakamoto Pharmaceutical Co Ltd(TSE:4512) is .
Does Wakamoto Pharmaceutical Co Ltd(TSE:4512) pay dividends? If so, how much?
The Dividend Yield %  of Wakamoto Pharmaceutical Co Ltd(TSE:4512) is 2.54% (As of Today), Highest Dividend Payout Ratio of Wakamoto Pharmaceutical Co Ltd(TSE:4512) was 5.28. The lowest was 0.45. And the median was 1.03. The  Forward Dividend Yield % of Wakamoto Pharmaceutical Co Ltd(TSE:4512) is 2.54%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers